Analyst Ratings for Moderna (MRNA)
MRNA Rating Summary
MRNA Price Target Summary
- Highest: $198.00 (Brookline Capital Markets)
- Lowest: $17.00 (Leerink)
- Average: $49.29
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$49.29 (-20.3%)
* Over Last 12-Mos
Rating Score: 1.7 / 10
Percentile Rank: 11%
Avg. $ Target:
$49.29 (-20.3%)
* Over Last 12-Mos
Rating Score: 1.7 / 10
Percentile Rank: 11%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/20/2026 | JPMorgan | Jessica Fye | New Coverage | Underweight (N/A) |
40.00 (N/A) |
48.11 (61.82) |
28.5% | Details |
| 1/28/2026 | Barclays » Updated 4/2/2026 |
Eliana Merle | New Coverage | Equalweight (N/A) |
48.00 (25.00) |
47.99 (61.82) |
28.82% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
